Registrieren Sie sich kostenlos
für unseren Newsletter!
für unseren Newsletter!
Loading...
Artikelnummer:
5600203
CAS Nr.:
646502-53-6
Formel:
C68H105N11O15
Molekulargewicht:
1316,63 g/mol
VcMMAE (mc-vc-PAB-MMAE) is a drug-linker conjugate for ADCs with potent antitumor activity by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the lysosomally cleavable dipeptide, valine-citrulline (vc). Monomethyl auristatin E (MMAE) is efficiently released from SGN-35 within CD30+ cancer cells and, due to its membrane permeability, is able to exert cytotoxic activity on bystander cells. MMAE sensitized colorectal and pancreatic cancer cells to IR in a schedule and dose dependent manner correlating with mitotic arrest. Radiosensitization is evidenced by decreased clonogenic survival and increased DNA double strand breaks in irradiated cells. Potential mode of action/Key words: Targeting Tubulin, Cytotoxic
Cfm Oskar Tropitzsch GmbH bietet auch Linker-Drug-Konjugate an. Entweder als verfügbares Linker-Drug Konjugat oder mittels Auftragssynthese speziell auf Ihre Wünsche zugeschnitten. Nehmen Sie für weitere Details Kontakt zu uns auf